Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed one-pot synthesis for 1,9-diazaphenalene derivatives. High yield, scalable process for OLED and pharma intermediates.
Patent CN107739322B details a novel Ir-catalyzed C-H activation route for sulfonamides. Discover cost-effective, high-yield manufacturing solutions for pharma and agrochemical intermediates.
Patent CN109251192A details Ir-catalyzed synthesis of trifluoromethyl isocoumarins. Offers high purity, mild conditions, and scalable supply chain solutions for pharmaceutical intermediates.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.
Novel copper-catalyzed C-H activation method for 8-thiaxanthine compounds. High yield, scalable process for pharmaceutical intermediates like KW-6002.
Patent CN113956208A reveals a metal-free, Eosin Y-catalyzed arylation method offering cost reduction in pharmaceutical intermediate manufacturing and scalable green chemistry solutions.
Novel C7-position stereospecific method enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally using cost effective ruthenium catalysis.
Novel Pd-catalyzed route for cis-fused beta-lactam compounds. Enhances supply chain reliability and reduces manufacturing costs for antibiotic intermediates.
Patent CN114507180A reveals an iodine-catalyzed method for synthesizing bis-heteroaryl ethylenes with 90% yield, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN112851674B reveals a novel rhodium-catalyzed double dehydrogenative coupling method for polysubstituted pyrroles, offering high efficiency and functional group diversity for industrial applications.
Novel Pd-catalyzed C-H activation method ensures 99% ee. Reliable supplier for scalable chiral amine manufacturing with cost efficiency.
Patent CN111777536A reveals a metal-free route to N-phenyl-3-(phenyldisulfanyl)propionamide using NFSI, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN108164435B details a solvent-free, Ru/C-catalyzed route for arylacrylonitriles, offering significant cost reduction and environmental benefits for pharmaceutical intermediate manufacturing.
Patent CN110642752A discloses a Pd-catalyzed selective alkenylation method yielding 45-98%, offering cost-effective routes for complex API intermediates and natural products.
Patent CN118619818A reveals mild Pd-catalyzed iodination technology. Enhances supply chain reliability for pharmaceutical intermediates. Offers high yield and functional group tolerance for scalable manufacturing processes.
Patent CN112299945A reveals a novel FeCl3-catalyzed method for alkyl olefin synthesis using DMSO. This breakthrough offers significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN115286573A reveals a cobalt-catalyzed green route for 1-alkoxy isoquinolines using deep eutectic solvents, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel Pd-catalyzed C-H functionalization route for aporphine alkaloids. Reduces synthetic steps, improves yield, and ensures supply chain stability for API intermediates.
Novel C-H activation method for spiro quinazolinones offers high yield and scalability for reliable pharmaceutical intermediate supply chains.
Patent CN105732586B reveals Pd-catalyzed route for high-purity substituted aspartic acid. Enables cost reduction and reliable supply chain for pharmaceutical intermediates manufacturing.